Phil King, fund managers flock to WA for ‘Rotto’ conference
Western Australia’s Rottnest Island hosted more than 600 people – including fund managers, family offices, and chief ...
Regal on watch over $200m biotech failure risk, shares dive
Investors have wiped more than $100m from the value of Regal Funds, amid fears that a position in one of its stocks – last ...
The Australian Financial Review10d
It’s Phil King’s Regal against the shorts at biotech play Opthea
It’s Phil King against the shorters at small-cap biotechnology play Opthea, which counts the veteran stockpicker’s Regal Partners as its biggest investor and is preparing to release the ...